Comparison of In Vitro and In Vivo Estrogenic Activity of UV Filters in Fish by Kunz, Petra Y. et al.
Comparison of In Vitro and In Vivo Estrogenic Activity of
UV Filters in Fish
Petra Y. Kunz,*,† Hector F. Galicia,‡ and Karl Fent*,§,1
*University of Applied Sciences Basel, Institute of Environmental Technology, St. Jakobs-Strasse 84, CH-4132 Muttenz, Switzerland; †University of Zu¨rich,
Institute of Plant Biology, Limnology, Seestrasse 987, CH-8802 Kilchberg, Switzerland; ‡Springborn Smithers Laboratories (Europe) AG, Seestrasse 21,
CH-9326 Horn, Switzerland; and §Swiss Federal Institute of Technology (ETH), Department of Environmental Sciences, CH-8092 Zu¨rich, Switzerland
Received July 28, 2005; accepted December 8, 2005
In this work, we evaluate whether in vitro systems are good
predictors for in vivo estrogenic activity in fish. We focus on UV
filters being used in sunscreens and in UV stabilization of
materials. First, we determined the estrogenic activity of 23 UV
filters and one UV filter metabolite employing a recombinant
yeast carrying the estrogen receptor of rainbow trout (rtERa) and
made comparisons with yeast carrying the human hERa for
receptor specificity. Benzophenone-1 (BP1), benzophenone-2 (BP2),
4,4-dihydroxybenzophenone, 4-hydroxybenzophenone, 2,4,4-
trihydroxy-benzophenone, and phenylsalicylate showed full dose–
response curves with maximal responses of 81–115%, whereas
3-benzylidene camphor (3BC), octylsalicylate, benzylsalicylate,
benzophenone-3, and benzophenone-4 displayed lower maximal
responses of 15–74%. Whereas the activity of 17b-estradiol was
lower in the rtERa than the hERa assay, the activities of UV
filters were similar or relatively higher in rtERa, indicating
different relative binding activities of both ER. Subsequently, we
analyzed whether the in vitro estrogenicity of eight UV filters is
also displayed in vivo in fathead minnows by the induction
potential of vitellogenin after 14 days of aqueous exposure. Of
the three active compounds in vivo, 3BC induced vitellogenin at
lower concentrations (435 mg/l) than BP1 (4919 mg/l) and BP2
(8783 mg/l). The study shows, for the first time, estrogenic
activities of UV filters in fish both in vitro and in vivo. Thus we
propose that receptor-based assays should be used for in vitro
screening prior to in vivo testing, leading to environmental risk
assessments based on combined, complementary, and appropriate
species-related assays for hormonal activity.
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INTRODUCTION
Numerous studies have focused on compounds that are
agonists for estrogen receptors a and b (ERa, ERb) (Routledge
and Sumpter, 1997; Schultz et al., 2000; Sohoni and Sumpter,
1998; Soto et al., 1991). These include a wide range of different
compounds having different molecular structures and binding
affinities that may induce effects in wildlife (Jobling et al.,
1998; Vos et al., 2000). With regard to the considerable number
of chemicals that are and will be assessed for possible
estrogenic activity, in vitro systems play an important role for
identification and first screening of estrogenic compounds that
interact with the ER. Within the framework on the Endocrine
Disrupters Testing and Assessment (EDTA) of the OECD,
animal and non-animal tests are proposed (OECD, 2002). For
assessing possible ecotoxicological effects, a fish in vivo
screening assay is planned, but no in vitro assays using fish-
based systems have been proposed (OECD, 2004). Considering
the vast number of compounds to be tested for aquatic systems,
it is important to employ appropriate in vitro systems for fish
(Ackermann et al., 2002; Le Gue´vel and Pakdel, 2001; Pakdel
et al., 2000). In this regard, the question arises as to what extent
in vitro systems can mimic in vivo activity of estrogenic com-
pounds. In vitro systems are cost-effective tools and allow for
rapid screening of a large number of compounds, but they have
limitations, which may result in unreliable predictions. There-
fore, the most appropriate way to determine the endocrine-
disrupting activity of chemicals seems to include both in vitro
and in vivo assays, as no single assay may be best suited to
determine the hormonal activity of a compound. In our pres-
ent work, we address this question, focusing on important
chemicals in personal-care products found in the aquatic
environment.
Sunscreens and cosmetics including lipsticks, skin lotions,
hair sprays, hair dyes, shampoos, and numerous other products
contain increasing amounts of compounds protecting from
ultraviolet (UV) radiation. Either organic UV filters, or in-
organic micropigments (ZnO, TiO2) scattering and reflecting
UV light, or combinations of both, are applied. Increased
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sunlight-protection factors are being used for preventing
negative effects on the human skin, which generally requires
higher percentages of UV filters in the products. Combinations
of different UV filters are increasingly employed for absorbing
UVA, UVB, and UVC light.
Inputs of UV filters into the aquatic system occur directly via
recreational activities (bathing) into surface water, and in-
directly via wastewater. Ultraviolet filters are photostable,
many of them highly lipophilic (log Kow 3–7) and relatively
stable in the aquatic environment (Balmer et al., 2005; Poiger
et al., 2004), which makes these compounds critical for
bioaccumulation. Residues of several UV filters have been
detected in human milk (Hany and Nagel 1995) and in fish
(Balmer et al., 2005; Nagtegaal et al., 1997), in the latter
between 21–3100 ng/g lipid, and also in lakes and wastewater,
with maximum concentrations up to 125 ng/l (Poiger et al.,
2004) and 19 lg/l (Balmer et al., 2005), respectively.
At present, the estrogenicity of UV filters in fish remains
elusive, and the ecotoxicological risk for aquatic life is not
known. Estrogenic activity in vitro has been shown for some
UV filters in MCF-7 cells (Schlumpf et al., 2001), recombinant
cell lines (Mueller et al., 2003; Schreurs et al., 2002), and
recombinant yeast systems carrying the human ERa (Kunz and
Fent, unpublished; Routledge and Sumpter, 1997; Schultz
et al., 2000). Estrogenic activity has also been observed exper-
imentally in vivo in rats (Durrer et al., 2005; Schlumpf et al.,
2001; Seidlova´-Wuttke et al., 2004). In fish, high concentra-
tions of 3-benzylidene camphor, 4-methyl-benzylidene cam-
phor, and octyl-methoxycinnamate (Holbech et al., 2002; Inui
et al., 2003) were found to be estrogenic after short-term
exposure. Contrary to these studies, no estrogenicity was ob-
served at 10 lM octyl-methoxycinnamate, benzophenone-3,
homosalate, octyl dimethyl-p-aminobenzoic acid, butyl
methoxydibenzoylmethane, and 1 lM 4-methyl-benzylidene
camphor after short-term exposure of transgenic zebrafish
(Schreurs et al., 2002). Therefore the estrogenic activity of
UV filters at low aqueous concentrations remains unclear.
The objectives of this study were to elucidate whether
commonly used UV filters are estrogenic in vitro and in vivo in
fish, to compare the in vitro activities in two in vitro systems
carrying either a fish or the human ERa, and to compare the
in vitro activity with the in vivo activity. We test the hypothesis
that the estrogenic activity of chemicals is best assessed by the
use of a tiered approach using a combination of in vitro and
in vivo assays of the same phyla. As the rtERa has a different
activity toward known estrogenic compounds than the hER
(Le Gue´vel and Pakdel, 2001; Pakdel et al., 2000; Petit et al.,
1995), the question arises whether fish-based in vitro systems
should be used for assessing estrogenicity in fish. Direct
comparison of fish in vitro and in vivo activity demonstrates
that the estrogenic activity in vivo may be partially predictable
from the in vitro activity, although in vitro screening tends to
overestimate the number of estrogenic compounds due to lack
of or low metabolism. This indicates the need for a tiered
approach, combining in vitro and in vivo assessments of
hormonal activity of UV filters for ecological risk assessment.
EXPERIMENTAL SECTION
Chemicals
17b-Estradiol (E2) was purchased from Fluka AG (Buchs, Switzerland).
Ultraviolet filters (Table 1) were obtained as follows. Benzophenone-1 (BP1),
benzophenone-2 (BP2), benzophenone-3 (BP3), benzophenone-4 (BP4),
4#-hydroxybenzophenone (4HB), 4,4#-dihydroxybenzophenone (4DHB),
2,4,4#-trihydroxybenzophenone (THB), 4-aminobenzoic acid (PABA), benzyl-
salicylate (BS), phenlysalicylate (PS), octyl salicylate (OS), octocrylene
(OC), and octyl dimethyl PABA (OD-PABA) were from Fluka AG; octyl-
methoxycinnamate (OMC), 3-(4#-methylbenzylidene-camphor) (4MBC),
3-benzylidene-camphor (3BC), and homosalate (HMS) were from Merck
(Glattbrugg, Switzerland). Ethoxylated ethyl-4-aminobenzoate (PEG-25 PABA),
a polymer consisting of ethyl 4-aminobenzoate and oxirane, was purchased
from Induchem (Volketswil, Switzerland), and isopentyl-4-methoxycinnamate
(IMC) was from Haarmann & Reimer (Holzminden, Germany). Bisimidazylate
(BIM) was purchased form T. H. Geyer (Friedrichsthal, Germany). 4-tert-Butyl-
4#-methoxydibenzoylmethane (BM-DBM) and 2-phenyl-5-benzimidazole-
sulfonic-acid (PBS) were purchased from Aldrich (Fluka AG, Buchs
Switzerland). 2,2-Methylenbis-phenol (ECL) was purchased from Ciba Speci-
ality Chemicals (Basel, Switzerland), and Uvinul A plus B (UAB), a mixture of
35% 2-(4-diethylamino-2-hydroxybenzoyl)-benzoic acid hexylester and 65%
OMC, was a gift from BASF AG (Wa¨denswil, Switzerland). All compounds
were >99% pure. Stock solutions were made in ethanol and stored in the dark at
4C. Analytical grade ethanol (EtOH, free of UV filters) was purchased from
T. J. Baker (Stehelin AG, Basel, Switzerland). Bidestilled water was produced
using a Jencons Autostill double D-ionstill destillator (Renggli AG, Rotkreuz,
Switzerland).
Experiments In Vitro in Yeast
Recombinant yeast assay expressing the rainbow trout estrogen receptor
alpha (rtERa assay). We investigated estrogenic activity of UV filters in vitro
by applying a quantitiative b-galactosidase assay in liquid culture of
recombinant yeast expressing the estrogen receptor of rainbow trout (rtERa)
that was kindly provided by F. Pakdel, University of Rennes. We slightly
modified the previously described assay procedure (Le Gue´vel and Pakdel,
2001; Petit et al., 1995). In general, the assay is based on transactivation of
rtERa and induction of b-galactosidase leading to a color change. The
estrogen-inducible expression system used is described in detail in (Le Gue´vel
and Pakdel, 2001). In brief, the yeast (Saccharomyces cerevisiae) genome
carries a stably integrated DNA sequence of the rainbow trout estrogen receptor
(rtERa). Yeast cells also contain expression plasmids carrying two estrogen-
responsive elements (ERE) upstream of the yeast proximal iso-1-cytochrome c
gene promoter fused to the lacZ gene (encoding the enzyme b-galactosidase).
Thus, the induction is strictly dependent on the presence of rtERa and estrogens
(Petit et al., 1995). When an active ligand (i.e., 17b-estradiol or an estrogenic
UV filter) binds to the receptor, b-galactosidase is synthesized and secreted into
the medium, leading to a catalytic hydrolysis of o-nitrophenyl-b-D-galactopyr-
anosid (ONPG) and resulting in the development of a yellow color, which was
measured as absorbance at 405 nm.
Preparation of rtERa assay media and yeast growth. The assay media
were prepared as previously published (Le Gue´vel and Pakdel, 2001; Petit
et al., 1995) and described (F. Pakdel, personal communication), with the
following amendments: Complete Minimal Dropout Medium (CM) was
prepared by adding 2% D-glucose instead of 1%. In addition to the CM
medium, we used YPD growth medium (2% peptone enzymatic digest from
meat, 2% D-glucose, and 1% yeast extract). Thus prior to the assay, yeast cell
growth was calculated as described (Petit et al., 1995), but with the
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TABLE 1
Chemical Structures, Molecular Weight, and CAS Numbers of Compounds Analyzed
Compound MW, (CAS) Chemical structure Compound MW, (CAS) Chemical structure
4MBC 3BC
254.37 (36861-47-9) 240.34 (15087-24-8)
BP1 BP2
214.22 (131-56-6) 246.22 (131-55-5)
4HB 4DHB
198.22 (1137-42-4) 214.22 (611-99-4)
THB BP3
230.22 (1470-79-7) 228.25 (131-57-7)
BP4 PBS
308.31 (4065-45-6) 274.30 (27503-81-7)
IMC OMC
248.32 (71671-10-2) 290.40 (5466-77-3)
OC BS
361.48 (6197-30-4) 228.25 (118-58-1)
PS HMS
214.22 (118-55-8) 262.35 (118-56-9)
OS PABA
250.33 (118-60-5) 137.10 (150-13-0)
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modification that yeast colonies from CM medium were inoculated in
Erlenmeyer flasks containing 15 ml of YPD growth medium instead of CM
medium, which lead to increasing growth rates and better assay performance.
rtERa assay procedure. The whole assay was performed as described in
detail elsewhere (Le Gue´vel and Pakdel, 2001; Petit et al., 1995), but instead of
hemolysis tubes in clear polystyrene, 96-well microplates (Greiner Bio-One,
Huber AG, Basel, Switzerland) were used, leading to small modifications of the
assay procedure according to Schultis and Metzger (2004). Thereby the
centrifugation step after cell lysis was excluded and the lysed suspension,
instead of the supernatant alone, was transferred to the flat-bottom 96-well
plate. The protein measure (Petit et al. 1995) was replaced by quantifying yeast
turbidity (A620), to assess and correct for yeast growth and as a control for
cytotoxicity. Cytotoxicity was manifested by significantly reduced yeast growth
or even cell lysis, and it was determined by absorbance at 620 nm. High
concentrations of some UV filters that lead to cytotoxicity were omitted from
curve fitting and calculations.
For screening of the UV filters, a 96-well V-bottomed microtiter plate was
filled with 100 ll/well S. cerevisiae cells in YPD culture. Three rows contained
serially diluted positive control E2, one row the ethanol blank, and four rows
the analyzed UV filter in quadruplicates with increasing concentrations,
resulting in dose–response curves. After cell lyses the lysed suspension was
transferred to a new flat-bottom 96-well plate (Greiner Bio-One, Huber AG,
Basel, Switzerland), ONPG was added, and the estrogenic activity was
measured as previously described (Le Gue´vel and Pakdel, 2001; Petit et al.,
1995; Schultis and Metzger, 2004).
The hERa recombinant yeast was kindly provided by J. Sumpter, Brunel
University, and the assay was performed according to Routledge and Sumpter
(1996) and Kunz and Fent (unpublished). The yeast (S. cerevisiae) genome
carries a stably integrated DNA sequence of the human estrogen receptor
(hERa), and it also contains expression plasmids carrying EREs, regulating the
expression of the reporter gene lacZ (encoding the enzyme b-galactosidase).
Thus, when an active ligand (i.e., E2 or an estrogenic UV filter) binds to
the receptor, b-galactosidase is synthesized and secreted into the medium,
leading to a color change of chromogenic substrate chlorophenol red b-D-
galactopyranoside (CPRG) from yellow to red.
Experiments In Vivo in Fish
Fish. The 14-days fish experiments were conducted using juvenile,
sexually undifferentiated fathead minnows (Pimephales promelas), between 2
and 3 months of age and with a total body length between 19 and 27 mm. This
fish species has been chosen because of its frequent use in the field of endocrine
disrupters and established techniques including vitellogenin (VTG) antibodies.
The experimental procedure and duration was similar to that of Panter et al.
(2002), who showed that estrogens and antiestrogens are detectable after
14 days of exposure by virtue of the VTG response.
Mixed-sex juvenile fathead minnows were received from the cultivator
(Aquatic Research Organisms, Hampton NH, USA) and adapted for a minimum
of 14 days in our laboratory in aquaria prior to the experiment. Fish were fed
with Tetramin pellets (Tetra GmbH, Melle, Germany) twice a day with
a quantity equivalent to 1% of body weight prior to the onset of experiments.
During the experiments, fish were fed with brine shrimp (Artemia salina,
Argent Chemical Labs, Redmond WA, USA) at a feeding rate of 1% of body
weight twice a day.
Exposure. Fish were held in well-aerated reconstituted tap water medium
(total hardness 160 mg/l as CaCO3, total alkalinity 30 mg/l as CaCO3,
TABLE 1—Continued
Compound MW, (CAS) Chemical structure Compound MW, (CAS) Chemical structure
PEG25-PABA (113010-52-9) OD-PABA
44.05 (75-21-8) 277.41 (21245-02-3)
165.2 (94-09-7)
BIM BM-DBM
275.40 (180898-37-7) 310.38 (70356-09-1)
ECL UAB
658.87 (103597-45-1) 397.52 (302776-68-7)
290.40 (5466-77-3)
Abbreviations: MW, molecular weight; CAS, Chemical Abstracts Service; 4MBC, 3-(4#-methylbenzylidene-camphor); 3BC, 3-benzylidene-camphor; BP1,
benzophenone-1; BP2, benzophenone-2; 4HB, 4-hydroxybenzophenone; 4DHB, 4,4#-dihydroxybenzophenone; THB, 2,4,4#-trihydroxybenzophenone; BP3,
benzophenone-3; BP4, benzophenone-4; PBS, 2-phenly-5-benzimidazole-sulfonic-acid; IMC, isopentyl-4-methoxycinnamate; OMC, octyl-methoxycinnamate;
OC, octocrylene; BS, benzylsalicylate; PS, phenlysalicylate; HMS, homosalate; OS, octyl salicylate; PABA, 4-aminobenzoic acid; PEG25-PABA, ethoxylated ethyl-
4-aminobenzoate; OD-PABA, octyl dimethyl PABA; BIM, bisimidazylate; BM-DBM, 4-tert-Butyl-4#-methoxydibenzoylmethane; ECL, 2,2-methylenbis-phenol;
UAB, Uvinul A plus B.
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conductivity 500 ls/cm) and a 16/8 h light/dark cycle at 25 ± 1C. The
studies were conducted using a 24-h static-renewal procedure with daily
renewal of total aquaria water. For exposure, 10 randomly selected fish were
each placed in stainless-steel tanks (10 liter) and exposed to individual UV
filters for 14 days. Not all UV filters evaluated in vitro could be analyzed
in vivo. To have a reasonable number of in vivo experiments, UV filters were
selected as follows: either because they exhibited maximal estrogenic activities
in our in vitro assays (BP1, BP2, 4DHB) or because they possessed submaximal
(BP3, BP4, 3BC) or no (4MBC, OMC) estrogenic activity in our in vitro assays
but were reported to be estrogenic by other studies, and because of their
frequent use.
The first experiment was performed with 4MBC, 3BC, BP1, and BP2, and
the second experiment was carried out with BP3, BP4, OMC, and 4DHB. In
both experiments two controls, solvent control (SC, 1 ml ethanol in 10 liters of
water) and positive control for estrogenic activity (100 ng/l E2), were included.
Stock solutions of each chemical were prepared freshly in ethanol prior to the
start of the experiment and added daily to the experimental water by mixing.
The following nominal concentrations of UV filters were used: 10, 100, 500,
1000, and 5000 lg/l for BP1, BP3, BP4, OMC, and 4DHB, respectively; 10,
100, 500, and 1000 lg/l for 4MBC and 3BC, respectively; and 10, 100, 500,
1000, and 10,000 lg/l for BP2.
The concentrations were selected on the basis of environmental residues and
included higher levels in order to span a large concentration range. Toxic side
effects (i.e., lethargy, uncoordinated swimming, loss of equilibrium, hyperven-
tilation) were observed for fish exposed to 5000 lg/l BP3 and 1000 lg/l 4MBC,
and the experiments were stopped at day 8 of exposure.
Physicochemicalmeasurementsandbiological observations. Physicochemical
parameters were determined daily. pH and oxygen saturation ranged between
7.2–7.9 and 6.5–8.3 mg/l, respectively, throughout the exposure period.
Mortalities and abnormal behavior were recorded daily, and dead fish were
removed from the tanks as soon as they were identified. On day 14 all fish were
anesthesized with buffered tricaine methane sulfonate (MS-222, 100 mg/l with
200 mg NaHCO3/l). Subsequently individual fish were measured, weighted,
transferred into labeled Eppendorf tubes, frozen, and stored at 20C for
homogenization and VTG analysis.
Vitellogenin analysis. Fish were defrosted at 4C and individually
homogenized in ice-cold assay buffer (Biosense, Bergen, Norway) in a 1:2 ratio
wet weight:buffer volume, using a Ultra Turax homogenizer (IKA, HuberþCo.
AG, Reinach, Switzerland). The homogenates were centrifuged at 10,000 3 g
for 3 min at room temperature using a microcentrifuge (Eppendorf centrifuge
5415 D, Vaudaux-Eppendorf AG, Scho¨nenbuch, Switzerland). The supernatant
was withdrawn and immediately used for vitellogenin (VTG) analysis or frozen
at 80C until required for VTG analysis. Whole-body homogenates were
assayed for VTG using a quantitative heterologous carp enzyme-linked
immunosorbent assay, which has been shown to be highly reliable for VTG
determination in the fathead minnow (Panter et al., 2002; Tyler et al., 1999). The
commercially available quantitative carp vitellogenin ELISA kit, which is based
on a sandwich ELISA format (Biosense), was used for determination of VTG in
whole-body homogenates of individual fish and was conducted as described by
Biosense. Purified carp VTG from blood plasma (Biosense) was used as
a standard for quantitation according to the provider’s description.
Analytical chemistry. For the duration of the experiment, four aliquots of
250 ml exposure waters were taken from the two highest and the two lowest
concentrations of each UV filter and controls at the beginning (0 h) and prior to
water renewal (24 h). The aliquots of the same concentration of UV filter were
pooled for each UV filter at each concentration and time point in brown glass
flasks, preserved by acidification using HCl to pH 2–3, and stored at 4C until
analysis. Chemical analyses of UV filter concentrations were carried out by high
performance liquid chromatography (HPLC) and UV detection (Kunz et al.
unpublished). Briefly, 25 or 250 ml of water samples, depending on sample
concentration, were extracted and concentrated by solid phase extraction (SPE).
The 25003 concentrated eluent was then analyzed by HPLC-DAD.
Data Processing and Statistical Analysis
Recombinant yeast assay. The absorbance measurement at 405 nm
(ONPG) and 620 nm (turbidity) for the rtERa assay allowed for subsequent
correction for turbidity (yeast growth) as follows:
Corrected absorbance¼ chemical absorbance405 nmchemical absorbance620 nm
½blank absorbance620 nmblank absorbance405 nm
For all UV filters, the maximal response relative to the standard (¼100%)
were calculated. Thereby the height of the UV filter dose–response curve was
expressed as a percentage of the maximal effect produced by the dose–response
curve of E2.
High concentrations of some UV filters that inhibited growth of the yeast, or
even lysed cells were omitted from curve fitting and calculations. For curve-
fitting and EC50 calculations (GraphPad Software Inc., San Diego, CA, USA),
the corrected absorbance values versus the logarithm of concentration were
plotted, whereby the best fit from a number of nonlinear regression models was
selected for final data analysis. In this study, we used the Hill equation (or
sigmoidal dose–response with variable slope) to fit full dose–response curves,
which reached the same height (80% maximal response) as the corresponding
standard E2. Moderate (30–80% maximal response) and submaximal (<30%
maximal response) dose–response curves were fitted using the best fit from
a number of non-linear regression models. Coefficient of determination (R2),
residuals and 95% confidence intervals were calculated, and the runs test was
carried out to verify that the fitted curve represents data correctly. Estrogenic
potencies were calculated for all active UV filters. Thereby the EC50 of UV
filters with full dose–response curves was divided by the EC50 of the E2
standard. For UV filters with submaximal dose–response curves, estrogenic
potencies were estimated based on their EC50 values, despite differences in
curve steepness and height when compared to the standards. In this way, a good
approximation of the estrogenic potencies of submaximal UV filters was
achieved.
Fish experiment. After testing the data distribution for normality by using
the Kolmogorov-Smirnov test, means of wet weight and total length of
individual fish were calculated, and data were analyzed by analysis of variance
(ANOVA) followed by a Dunnett’s Multiple Comparison test to compare the
treatment means with respective controls. Means of VTG concentrations of
individual fish were calculated, and data were analyzed with the non-parametric
Kruskal-Wallis test, followed by a Dunn’s Multiple Comparison test to compare
the treatment means with respective controls. Statistical comparisons with the
control were made using the SC as the overall control. The results are given as
mean ± standard error of mean (SEM). Differences were considered significant
at p  0.05. All computations were performed with PRISM 4.0 (GraphPad
Software Inc.).
RESULTS
Estrogenic Activity of UV Filters In Vitro
Ten of 23 analyzed UV filters and the UV filter metabolite
4HB were found to possess estrogenic activity in the recombi-
nant yeast assay expressing the rainbow trout ERa. BP1, BP2,
4DHB, THB, 4HB, and PS were full rtERa agonists exhibiting
full dose–response curves. They had maximal responses of
81–123% as compared to E2 (Fig. 1). Moderate, but clear
dose–response curves were found for BS, BP3, and BP4,
characterized by lower maximal responses of 43–74% (Fig. 1).
Submaximal dose–response curves were observed with 3BC
and OS with maximal responses of 27% and 15%, respectively
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(Fig. 1). Table 2 shows the relative potencies of the UV filters
compared to E2, as determined by their half-maximal induction
activities (EC50). The most potent UV filter was BP1, which
was only 87 times less potent then E2. Estrogenicity decreased
in the following order 4HB > 3BC > BS > BP2 > BP3 > THB >
PS > 4DHB > BP4 > OS. The estrogenic potencies were in the
range of 390 to 24,750 times lower than E2. The remaining 12
UV filters, namely 4MBC, BIM, BM-DBM, ECL, HMS, IMC,
OC, PABA, OD-PABA, PEG25-PABA, OMC, PBS, and UAB
were inactive up to 2.53 102 M. In every assay we checked for
potential cytotoxicity caused by the UV filter by routinely
measuring yeast growth (620 nm) besides b-galactosidase
activity (405 nm). Hence UV filter concentrations, which lead
to reduced yeast cell growth or complete growth inhibition, were
omitted from data analysis for hormonal activities. At high
concentrations slight cytotoxicity occurred for BS (5.04 3
105 M), BP4 (10.0 3 104 M), 4DHB (1.00 3 103 M)
and PS (1.00 3 104 M). Hormonal activity was therefore
assessed at non-cytotoxic concentrations only.
Comparison with hERa. The same UV filters found active
in our present study with recombinant yeast expressing the
rainbow trout ERa were previously found active in a re-
combinant yeast system expressing the human estrogen re-
ceptor alpha (hERa). With this system, we investigated 17 UV
filters and one metabolite for their multiple hormonal activities
such as estrogenicity, antiestrogenicity, androgenicity, and
antiandrogenicity in vitro (Kunz and Fent, unpublished). The
only exception was OS that exhibited minimal estrogenic
activity in the rtERa only. The activities of BP1, 3BC, and the
salicylates were relatively higher with rtERa than with hERa,
but they were lower for the remaining benzophenones,
displaying lower EC50 values with hERa. BP1 and 4HB
showed strongest activities in both receptor systems. The
rankings of the other UV filters differed between the receptor
systems, however. In the hERa assay benzophenone derivatives
were the most potent compounds. Benzophenone-, camphor-,
and salicylate derivatives were most potent in the rtERa assay.
The maximal responses of estrogenic compounds in the rtERa
assay were in most cases higher than in the hERa, with only
BP2 and 4DHB as exceptions (Table 2). A direct comparison of
the two assays is shown in Figure 2. BP1 as the most potent UV
filter in both assays displayed an estrogenic activity only 87
times less than that of E2 with rtERa and 5000 times less with
hERa. In particular, the relative activity of 3BC was higher in
the rtERa assay. In contrast to the relatively higher activity of
UV filters in the rtERa assay, the hERa assay was 62 times
more sensitive toward E2.
Estrogenic Activity of UV Filters in Fish In Vivo
Measured exposure concentrations. To determine actual
effect concentrations and to get an estimate of concentration
decrease, concentrations of UV filters in aquaria waters were
measured at the beginning of exposures (0 h) and 24 h later,
prior to water renewal at the lowest and the two highest
exposure concentrations. Concentrations decreased during
exposure, but to a variable extent for different compounds.
Table 3 shows that actual concentrations determined by
HPLC analysis were close to nominal. After 24 h before
water renewal, concentrations decreased to various degrees
(0–32%) depending on compound and concentration. The
different concentration decreases are a result of different
physicochemical properties of UV filters (lipophilicity) and
uptake by fish.
Effects of UV filters on fish survival, weight, and length. No
mortality was observed in control, solvent control (SC), and
positive control (E2) exposed fish in either experiment. The UV
filters did not affect survival during exposure, except at the
highest concentrations of 4MBC, 3BC, and BP1. After 8 days
of exposure, two fish died at 753 lg/l 4MBC (survival 80%),
and the experiment was stopped. At 953 lg/l 3BC and 4919 lg/l
BP1, one fish each was found dead at day 12 and day 11,
respectively. Fish at 8783 lg/l BP2 showed some signs of
edema at the end of exposure.
During the 14-day exposures, all control, SC, and E2 fish
grew as determined by increase in wet weight and total body
length (Table 4). At low concentrations of UV filters no
FIG. 1. Estrogenic activity of UV filters in the rtERa assay, shown in two
panels (A, B) for clarity. Data shown are means ± SEM (three experiments with
four replicates each). Effect (%) represents percentage of b-galactosidase
induction of UV filters versus solvent (0%) and E2 (100%) controls. Results for
inactive chemicals are not shown for clarity. Compound abbreviations see Table 1.
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significant differences from controls were observed. Length
gain was significantly decreased for 435 and 953 lg/l 3BC and
4MBC (Table 4), however. No difference occurred in wet
weight and mean length in the SC and E2. 3BC and 4MBC led
to a dose-related decrease in the weight gain and body length at
435 and 953 lg/l, and 415 and 753 lg/l, respectively. No
decreases in body weight gain and body length were observed
with all other UV filters at all exposure concentrations, except
for 4919 lg/l BP1 after 14 days of exposure.
Estrogenicity of UV filters. Significant VTG induction
occurred in fish exposed to ng/l E2. Mean whole-body VTG
content was 2600 lg/ml and was highly induced compared
to the water and solvent control having a residual level of
0.3 lg/ml. Dose-dependent increases in VTG were observed
in fish exposed to 3BC, BP1, and BP2 (Fig. 3). 3BC showed
higher VTG induction and at lower concentration compared
to BP1 and BP2. Dose-related significant VTG induction oc-
curred at 3BC concentrations of 435 lg/l (407 lg VTG/ml)
and 953 lg/l (1753 lg VTG/ml). Concentration-related VTG
induction was also found after exposures to higher concen-
trations of BP1 and BP2. Although increased at medium
concentrations, VTG induction was significant only at the
highest concentrations of BP1 and BP2, namely at 4919 lg/l
BP1 (907 lg VTG/ml) and 8783 lg/l BP2 (1504 lg VTG/ml).
The UV filters BP3, BP4, and 4DHB did not result in
a significant VTG induction at all exposure concentrations in
fish, although they showed submaximal estrogenic activity
in vitro. 4MBC and OMC, which showed no estrogenicity
in vitro, were not estrogenic in vivo. Therefore, three of five UV
filters that exhibited estrogenic activity in vitro were also
estrogenic in vivo.
TABLE 2
Comparison of In Vitro (rtERa, hERa) and In Vivo Effect Concentration
In vivo In vitro
VTG Induction rtER assay EC50 hER assay EC50
Sensitivity
Ratio EC50









E2 0.1 3.67 31010 4.93 1.81 3 108 ±
5.12 3 109
100% 1 0.08 2.91 31010 ±
1.19 3 1010
100% 1 62.00
4MBC n.e. n.e. n.e. —
3BC 953 3.96 3 106 2927.00 1.22 3 105 27% 960 74,443.00 3.10 3 104 21% 1.3 3 106 0.04
435 1.81 3 106
BP1 4919 2.30 3 105 171.26 7.99 3 107 114% 87 247.15 1.15 3 106 96% 5000 0.70
BP2 8783 3.57 3 105 6141.00 2.49 3 105 88% 2690 2684.00 1.09 3 105 91% 21,000 2.30
4DHB n.e. 36,867 1.72 3 104 88% 23,340 15,727.00 7.34 3 105 91% 170,000 2.30
4HB — 586.73 2.96 3 106 111% 390 360.56 1.82 3 106 108% 16,000 1.60
THB — 10,506.00 5.30 3 105 123% 7890 1818.00 9.17 3 106 103% 27,730 5.80
BP3 n.e. 4999 2.19 3 105 62% 3470 4237.00 1.86 3 105 18% 45,000 1.20
BP4 n.e. 91,846.00 2.98 3 104 43% 24,750 29,241.00 9.48 3 105 6% 380,000 3.10
IMC — n.e. n.e. —
OMC n.e. n.e. n.e. —
OC — n.e. n.e. —
BS — 2614.00 1.15 3 105 74% 1800 37,872.00 1.66 3 104 12% 860,000 0.07
PS — 6704.00 3.13 3 105 81% 8200 23,648.00 1.10 3 104 32% 480,000 0.30
HMS — n.e. n.e. —
OS — 964,772.00 3.85 3 105 15% 570,000 n.e. —
PABA — n.e. n.e. —
PEG25 PABA — n.e. n.e. —
OD-PABA — n.e. n.e. —
BIM — n.e. n.e. —
BM-DBM — n.e. n.e. —
ECL — n.e. n.e. —
UAB — n.e. n.e. —
Abbreviations: E2, 17b-estradiol; EC50, the concentration of the compound exhibiting 50% of its total effect. n.e., no effect. Values for E2 standard are given
in mean S.E.M. of 10 (rtERa) or 9 (hERa, Kunz et al., unpublished) experiments, respectively with three replicates each. EC50 values of compounds are from
three experiments with four replicates each. Potency ¼ EC50 compound/EC50 E2 is calculated from mean values of each single experiment; the used EC50
values for E2 in each experiment are not listed here for reasons of simplicity. Chemical concentrations shown for the in vivo assay are those at which VTG was
significantly induced relative to the solvent control. For compound abbreviations see Table 1.
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DISCUSSION
In the present study we show that it is most appropriate to
determine the endocrine-disrupting activity of chemicals both
in vitro and in vivo, preferably in a tiered approach, as no single
assay may be best suited to determine the hormonal activity of
a compound and because of species differences. In this way, we
demonstrate for the first time that as many as 10 of 23
commonly used UV filters are estrogenic in an in vitro yeast
assay carrying a fish ER (rtER). Compared to our results in the
recombinant yeast carrying the hERa, where we investigated 17
UV filters and one metabolite for estrogenicity, antiestrogenic-
ity, androgenicity, and antiandrogenicity in vitro (Kunz and
Fent, unpublished), we found that all compounds, except OS,
were equally estrogenic in both assays, despite lower activity of
E2 in the rtERa assay. In fish we demonstrated that three of
eight UV filters were estrogenic in vivo. Comparing in vitro
activities in two systems with fish in vivo activity, we found the
rtERa in vitro data more accurate than the hERa data for
prediction of the in vivo activity. Hence estrogenic activity of
chemicals is best assessed by the use of a tiered approach with
a combination of in vitro and in vivo assays of the same species.
In Vitro Activity in the rtERa Assay
We found 10 of 23 compounds exhibiting estrogenic
activities in the rtERa assay with different maximal responses
FIG. 2. Comparison of estrogenic activity of UV filters between the rtERa
(bold lines) and the hERa (dashed lines) assay, shown in three panels (A, B, C)
for clarity. Data shown are means and 95% confidence intervals (three
experiments with four replicates each). Effect (%) represents percentage of
b-galactosidase induction of UV filters versus solvent (0%) and E2 (100%)
controls. Results for inactive chemicals are not shown for clarity. Compound
abbreviations see Table 1.
TABLE 3









3BC 10 9.5 ± 0.3 8.0 ± 1.2 9 84
500 516.7 ± 36.7 352.5 ± 130.8 435 68
1000 1070.0 ± 28.3 835.0 ± 49.5 953 78
BP1 10 9.8 ± 0.1 8.1 ± 0.2 9 82
1000 1032.4 ± 54.8 930.0 ± 14.1 981 90
5000 5191.7 ± 58.7 4647.1 ± 221.4 4919 90
BP2 10 10.7 ± 0.6 9.9 ± 0.9 10 93
1000 1102.5 ± 9.8 1031.7 ± 17.0 1067 94
10,000 9747.3 ± 557.9 7818.5 ± 104.5 8782 80
4MBC 10 9.6 ± 1.8 7.4 ± 0.4 9 77
500 492.4 ± 102.7 337.5 ± 17.7 415 69
1000 826.1 ± 189.4 680.0 ± 198.0 753 82
OMC 10 8.8 ± 0.1 6.5 ± 0.7 8 74
1000 1012.5 ± 165.6 765.0 ± 63.6 889 76
5000 5450.0 ± 282.8 4600.0 ± 141.4 5025 84
BP3 10 13.5 ± 1.1 9.7 ± 0.2 12 71
1000 879.5 ± 115.0 652.2 ± 65.4 766 74
5000 4175.0 ± 247.5 3625.0 ± 106.1 3900 87
BP4 10 11.5 ± 0.9 10.8 ± 0.8 11 94
1000 1068.2 ± 64.4 1027.7 ± 99.2 1048 96
5000 5158.9 ± 425.2 4634.3 ± 26.4 4897 90
4DHB 10 11.8 ± 1.0 9.0 ± 0.1 10 76
1000 901.9 ± 48.4 899.0 ± 42.9 900 100
5000 5388.5 ± 2.7 4633.0 ± 232.4 5011 86
aMedian of actual concentrations at 0 h and 24 h.
bPercentage of actual concentration at 24 h relative to 0 h.
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and dose–response curves. The range of moderate to full dose–
response curves can be explained by the molecular structures.
Ultraviolet filters displaying full dose–response curves are
characterized by at least one ring-substituted hydroxyl group.
They display lower maximal responses with increasing molec-
ular symmetry. Additional substituents on the phenolic ring
have a diminishing effect on the maximal estrogenic responses
in both ERa systems (Kunz and Fent, unpublished; Routledge
and Sumpter, 1997). This is the case for BP3, BP4, BS, OS, and
3BC, which are substituted with methoxy-, sulfonic acid-,
benzyl, octyl, or camphor groups, possibly indicating only
partial agonism. Like those compounds with very large
molecular structures that prevent uptake into cells, inactive
UV filters had, with very few exceptions, only one non-
hydroxylated ring that was connected and/or attached to other
substituents such as ethoxy, alkyl-, amino-, cyano-, or me-
thoxy-groups, which were shown to significantly decrease the
chemical’s affinity for the rtERa, as previously shown for
hERa (Blair et al., 2000). The structural basis of the estrogenic
UV filters found in our study is in line with recent findings on
structure–activity relationships of structurally similar chem-
icals in hER-systems (Miller et al., 2001; Routledge and
Sumpter, 1997; Schultz et al., 2000).
Comparison Between Rainbow Trout and Human ERa
We were interested in elucidating whether the structural
differences between human and rainbow trout ERa (Petit et al.,
1995, 2000) were responsible for functional differences.
Homologies in amino acid sequences between hERa and
rtERa are variable, depending on domain (Pakdel et al.,
1990). The most highly conserved region is the C domain
(92% homology), which is responsible for DNA binding and
dimerization (Petit et al., 2000). Whereas rtERa and hERa
have similar binding affinities to an estrogen response element,
the rtERa C domain is responsible for a weaker DNA binding
stability. The E domain shares 60% similarity with rtERa and
hERa and contains the hormone-binding domain. Petit et al.
(1995) found that the rtERa has a lower affinity for E2 than the
hERa. This was further demonstrated for 17b-estradiol,
estrone, and 17b-ethinylestradiol (Le Gue´vel and Pakdel,
2001) and is confirmed by the present study; the E2
TABLE 4
Body Weight and Length of Exposed Fish after 0 and 14 Days of Exposure
Exposure (lg/l) Body weight (mg) Body length (mm) Exposure (lg/l) Body weight (mg) Body length (mm)
Controls Day 0 62.0 ± 24.4 18.9 ± 2.2 Controls Day 0 161.3 ± 45.7 27.4 ± 2.1
Water 211.3 ± 91.1 29.4 ± 2.8 Water 313.1 ± 80.0 33.8 ± 3.1
Solvent 238.0 ± 88.8 30.8 ± 3.5 Solvent 277.0 ± 62.2 32.0 ± 2.2
E2 249.0 ± 111.8 29.6 ± 4.1 E2 282.9 ± 70.7 32.4 ± 2.6
4MBC 9 272.4 ± 82.9 31.1 ± 2.9 BP3 12 313.9 ± 59.9 34.6 ± 2.0
100 237.3 ± 60.6 30.4 ± 2.4 100 317.5 ± 105.4 33.3 ± 3.7
415 103.9 ± 40.8** 23.6 ± 2.6** 500 281.6 ± 123.7 32.7 ± 3.5
753 43.1 ± 25.2** 17.1 ± 3.6** 766 257.3 ± 51.1 32.0 ± 1.7
3#900 134.6 ± 36.6** 27.9 ± 2.2*
3BC 9 335.9 ± 128.9* 32.8 ± 3.1
100 258.9 ± 95.9 30.9 ± 3.4 BP4 11 330.5 ± 114.6 34.2 ± 4.4
435 115.1 ± 37.4** 24.7 ± 2.4** 100 326.4 ± 102.2 33.4 ± 3.0
953 95.8 ± 25.8** 23.7 ± 1.8** 500 309.2 ± 69.3 34.1 ± 1.9
1#048 299.9 ± 57.8 33.5 ± 1.7
BP1 9 246.5 ± 77.0 30.0 ± 2.6 4#897 375.4 ± 97.5* 35.5 ± 2.8*
100 273.1 ± 141.2 31.7 ± 4.6
500 240.4 ± 67.8 30.5 ± 2.1 OMC 8 303.3 ± 114.5 33.4 ± 3.6
981 245.0 ± 90.0 29.4 ± 3.8 100 266.7 ± 54.5 32.4 ± 2.5
4#919 121.9 ± 46.9* 24.6 ± 3.2** 500 283.3 ± 62.6 32.8 ± 1.8
889 303.2 ± 65.8 33.2 ± 2.2
BP2 10 272.9 ± 125.7 30.9 ± 4.9 5#025 267.4 ± 60.5 32.4 ± 2.1
100 264.5 ± 116.9 30.6 ± 4.1
500 247.6 ± 73.7 30.5 ± 2.2 4DHB 10 321.8 ± 70.2 34.7 ± 1.1
1#067 293.4 ± 113.4 32.1 ± 3.6 100 316.9 ± 111.4 34.0 ± 3.4
8#783 171.4 ± 35.0 25.9 ± 1.8** 500 340.9 ± 102.2 34.4 ± 3.0
900 351.4 ± 93.7 34.5 ± 2.6
5#011 371.5 ± 97.0 35.5 ± 3.0*
E2: 17b-estradiol.
*Significantly different from solvent control at p < 0.05.
**Significantly different from solvent control at p < 0.01.
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concentration necessary to induce 50% activity was 62 times
higher in the rtERa assay. The weaker magnitude of E2
stimulation mediated by rtERa is attributed to the lower
DNA-binding stability and not to structural differences be-
tween the two ER (Petit et al., 2000).
As for most of the UV filters, relative sensitivities of rtERa
and hERa systems varied very little (one order of magnitude),
indicating that the main difference between the two receptors is
their sensitivity for E2 (Table 2). Differences between the two
ER occurred for the salicylate derivatives (PS, BS, OS), which
showed several times higher activity in rtERa, and for 3BC,
which showed as much as 1300 times higher activity than in the
hERa. Maximal responses were generally higher in the rtERa
assay, except for BP2 and 4DHB. This indicates a higher
relative sensitivity and weaker partial agonism in the rtERa of
compounds showing submaximal activity.
Thus, in contrast to the lower activity of E2, the activity of
some UV filters is relatively higher in the rtERa assay. This
cannot be fully explained by a lower DNA-binding stability
found by Petit et al. (2000) for estradiol, but is rather attributed
to structural differences of the two ER and the molecular
structure of the UV filters interacting with the ER. This points
toward a slightly different substrate binding specificity of the
fish and human ERa based on differences in the binding
domain of the two receptors. In addition, differences in the
transactivation process such as dimerization and DNA-binding
capacity may also account in part for the different relative
sensitivities. Forthcoming studies focusing on UV filter re-
ceptor binding and influence on the transactivation process will
elucidate the reasons for the differing sensitivities of the fish
and hERa.
Comparison with Other In Vitro Studies
The estrogenicity of UV filters found in our study with rtERa
is consistent with results obtained in vitro in human ER
systems, although relative sensitivities may differ. Estrogeni-
city of some salicylate and camphor derivatives have been
reported in mammalian systems such as recombinant yeast
(Kunz and Fent, unpublished; Miller et al., 2001; Mueller et al.,
2003), receptor binding assays (Blair et al. 2000; Mueller et al.,
2003; Schlumpf et al., 2004), proliferation of MCF-7 cells
(Schlumpf et al., 2001, 2004), and reporter gene induction in
transfected cell lines (Schreurs et al., 2002; Suzuki et al., 2005;
Yamasaki et al., 2003). The estrogenicity of BP1, BP2, BP3,
and 3BC found in our rtERa assay is consistent with findings in
MCF-7 cells (Schlumpf et al., 2001, 2004), reporter hERa/
HeLa cells (Yamasaki et al., 2003), MCF7 reporter cells
(Suzuki et al., 2005), and HEK293 cells (Schreurs et al.,
2005). Our results are also consistent with the hERa cell assay
for BP3, but not for 4MBC in the HEK 293 reporter gene assay.
In addition, 3BC, HMS, and 4MBC showed activity in the
hERa assay (Schreurs et al., 2002).
In fish, at least two ER subtypes, ERa and ERb, occur, and in
zebrafish, a third form has been reported (Menuet et al., 2002).
At present it is not known to what extent UV filters interact
with these receptors. Reasons for differences between results
obtained in our study with the rtERa assay and other in vitro
assays are, first, that UV filters may be active toward the ERb,
but not the ERa. In the MCF-7 and other human cells, active
UV filters may interfere with both hERs. 4MBC was estrogenic
in the MCF-7 cells (Schlumpf et al., 2001), but it did not
exhibit estrogenic activity toward the rtERa in the present
study, a finding similar to that previously reported from our
experiments with the hERa (Kunz and Fent, unpublished),
based on the fact that 4MBC binds preferably to the ERb
(Schlumpf et al., 2004). This is also the case for HMS
(Schreurs et al., 2002). In addition, yeast has only a low
capability for metabolism; therefore metabolites of UV filters
binding to the ER are not identified by the rtERa assay. The
differences may also depend in part on different binding
activities of the ERs of different species and on differences
between in vitro assays and their varying capabilities to activate
a chemical metabolically. This leads to the conclusion that
species differences in the estrogenic activity occur and that one
FIG. 3. Vitellogenin concentration in juvenile fathead minnows exposed to
eight UV filters. Values are means ± SEM (n¼ 10). Asteric denotes a significant
difference from control (solvent) at p  0.05. Concentrations given as actual
median measured, except 100 and 500 lg/l.
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in vitro assay alone is not sufficient for assessing the estro-
genicity of chemicals and fully characterizing their estrogenic
potential. Moreover homologous in vitro systems are more
reliable for predicting in vivo activity.
Comparison of In Vivo Activities
Our in vivo experiments demonstrate that of eight analyzed
UV filters, three—3BC, BP1, and BP2—showed estrogenic
activity in fathead minnows. 3BC led to dose-dependent
induction of VTG at lower concentrations (435, 953 lg/l) than
BP1 (4919 lg/l) and BP2 (8783 lg/l). 4MBC, OMC, BP3, BP4,
and 4DHB did not induce VTG up to the highest concentrations
in the range between 753 lg/l (4MBC) and 5010 lg/l (4DHB).
Schreurs et al. (2002) observed no estrogenicity in transgenic
zebrafish exposed for 96 h at 10 lM of OMC (2.90 mg/l), OD-
PABA (2.77 mg/l), HMS (2.62 mg/l), BP3 (2.28 mg/l), and
1 lM of 4MBC (0.25 mg/l), which is consistent with our data
with these UV filters analyzed at similar concentrations but for
a longer period of time. Injection of high concentrations of
3BC (27, 68, 137 mg/kg and higher) induced VTG in rainbow
trout (Holbech et al., 2002). In medaka, estrogenic activity of
4MBC and OMC was observed only at about 200 times higher
concentrations (Inui et al., 2003), but it was not found at 20
times higher concentrations than in our study. This may be
related to species-specific differences in VTG induction. The
relative degree of VTG induction is species-specific, as shown
for rainbow trout that reacted with higher VTG induction to
endocrine disrupters than roach (Routledge et al., 1998).
The UV filters 4MBC, BP3, 4DHB, and OMC exhibited
estrogenicity in vivo in rats (Mueller et al., 2003; Schlumpf
et al., 2001, 2004; Yamasaki et al., 2003), but this was not
observed in our fish study. The differences can be explained by
species differences in metabolism and different affinities to the
ERs, as 4MBC and HMS preferably bind to the ERb (Schlumpf
et al., 2004; Schreurs et al., 2002). Whether this is the case in
fish is not known. Most likely, the differences are based on the
different metabolic capabilities of fish compared to rats, but
also on lower exposure concentrations. In our fish experiments,
UV filter levels in water were lower than in rats exposed to UV
filters via feed.
Comparison of In Vitro and In Vivo Activity
The estrogenic activity in vitro was matched in vivo for
most UV filters. 4MBC and OMC exhibited neither estrogenic
activity in in vitro transactivation assays carrying either the
hERa or rtERa nor in fish in vivo. 3BC, BP1, and BP2 showing
activity in vitro were also active in vivo. Both in vitro and
in vivo, they possessed the highest potencies of the tested UV
filters. The in vitro activity of BP1 (EC50 7.9 3 107 M) was
higher than that of 3BC (1.2 3 105 M), whereas BP2 was the
least active of these three compounds, both in vitro and in vivo
(Figs. 1–3). The in vivo activity of 3BC was higher than
expected from its in vitro potency in the rtERa assay, where it
was the second most potent UV filter after BP1. Being only 87
times less active than E2 in the rtERa assay, BP1 showed only
weak in vivo activity in fathead minnows. This might be
explained by its higher metabolism and lower lipophilicity (and
lower bioaccumulation potential) compared to the more lipo-
philic 3BC. Furthermore, the relatively higher estrogenicity of
3BC in vivo might be based on the higher binding activity of
3BC to the ERb than to ERa of fathead minnows, as 3BC binds
preferentially to human recombinant ERb, and only slightly to
ERa (Schlumpf et al., 2004). There are no indications that
metabolites of 3BC are more active than the parent compound.
On the basis of the rtERa assay, the relatively low in vivo
activity of BP2 is consistent with our in vitro data. This might
also be the reason why 4DHB, BP3, and BP4 possess lower
rtERa potencies. The estrogenic activity of most benzophenones
and salicylates seems to be abolished in vivo because of
metabolism.
In comparisons of the potency rankings of UV filters for the
rtERa and the hERa assay, the data clearly demonstrate that the
rtERa in vitro data are more accurate than the hERa data in
predicting the in vivo activity. This indicates that hormonal
activity of UV filters should be assessed by a suite of species-
related in vitro and in vivo assays in which the in vitro assay
should be able to predict to most potent compounds for further
in vivo testing. Differences in in vitro and in vivo activities,
which we nevertheless observed in our fish-based assays, are
attributable to metabolism, and also to different activities to
different ERs in fish. Our approach using rtERa in vitro and
fathead minnow in vivo may cover species differences in fish.
Perhaps using the same fish species (rainbow trout) in the
in vivo assay as in the in vitro assay would have resulted in
more comparable results between the in vitro and in vivo
assays.
Environmental Consequences
In the environment only a few UV filters such as OC, 4MBC,
BP3, and BM-DBM have been analyzed to date. In lake water,
BP3, 4MBC, and OC occurred at concentrations of 80–125,
60–80, and 22–27 ng/l, respectively, in the upper layer of
a bathing lake (Poiger et al. 2004), but they were lower in other
lakes (Balmer et al., 2005). Concentrations in treated waste-
water were 0.06–2.7 (4MBC), 0.01–0.7 (BP3), 0.01–0.1
(OMC), and 0.01–0.27 lg/l (OC) (Balmer et al., 2005).
Residues of 4MBC, OMC, BP3, and HMS were also found
in muscle tissue of fish from a German lake at levels between
21 and 3100 ng/g lipid (sum of all UV filters 2 lg/g in perch
and 0.5 lg/g in roach), and between 25 and 166 ng/g lipid in 10
whitefish from Swiss lakes (Balmer et al., 2005). However,
3BC, BP1, and BP2, which were found in our study to be
estrogenic, have not yet been analyzed in aquatic systems. If
they were in the same range, VTG induction after short-term
exposure to a single UV filter would probably not pose a hazard
to fish. However, different UV filters may act additively
ESTROGENIC ACTIVITY OF UV FILTERS IN FISH 359
(Heneweer et al., 2005), as indicated for other endocrine
disrupters (Routledge et al., 1998). Moreover, long-term
exposure to UV filters may affect fish reproduction at much
lower concentrations.
As it is not known to what extend these UV filters occur in
the environment and in fish, comprehensive hazard and risk
assessment is premature. Forthcoming studies should deter-
mine environmental concentrations of estrogenic UV filters and
to relate them to effect concentrations. For hazard and risk
assessment, potential effects on reproduction, fecundity, and
fertility in fish are necessary, as are bioaccumulation studies.
Moreover, UV filters may have multiple hormonal activities
such as antiestrogenicity, androgenicity, and antiandrogenicity,
in addition to estrogenicity (Kunz and Fent, unpublished).
Whether these multiple hormonal activities are reflected in vivo
in fish, and whether reproduction effects occur, is now under
investigation in our laboratory.
CONCLUSIONS
Considering the vast number of compounds to be tested for
possible endocrine activity, it is important to employ appro-
priate in vitro systems. They are cost effective and allow for
rapid screening of a large number of compounds, but they have
limitations that may result in unreliable predictions. In the
present study we show that it is most appropriate to determine
the endocrine-disrupting activity of chemicals both in vitro and
in vivo, as no single assay appears to be best suited to determine
the hormonal activity of a compound, and because there are
species differences. We propose that receptor-based assays
with related or even the same species should be used for in vitro
screening prior to in vivo testing. In this tiered approach, the
predictive power of in vitro systems is enhanced, and cost
intensive in vivo studies can be reduced by employing species-
specific in vitro assays. This leads to the conclusion that an
environmental risk assessment should be based on combined,
complementary, and appropriate species-related in vitro and
in vivo assays for hormonal activity.
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